Human TACI / TNFRSF13B Protein, His Tag
分子別名(Synonym)
CD267,TACI,TNFRSF13B
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human TACI, His Tag (TAI-H52H3) is expressed from human 293 cells (HEK293). It contains AA Ser 2 - Thr 166 (Accession # O14836-1).
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 20.5 kDa. The protein migrates as 19-22 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, 0.2 M Arginine, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
跨膜激活劑和CAML相互作用物(TACI),也稱為腫瘤壞死因子受體超家族成員13B(TNFRSF13B)。最初發(fā)現(xiàn)它是因?yàn)樗軌蚺c鈣調(diào)節(jié)劑和親環(huán)素配體(CAML)相互作用。后來發(fā)現(xiàn)TACI通過與TNF家族的兩個(gè)成員BAFF和APRIL相互作用,在體液免疫中起著至關(guān)重要的作用。
本研究表明,在非小細(xì)胞肺癌中,增殖誘導(dǎo)配體(APRIL)、B細(xì)胞成熟抗原(BCMA)和跨膜激活物和CAML相互作用物(TACI)蛋白通過免疫組織化學(xué)、逆轉(zhuǎn)錄定量聚合酶鏈?zhǔn)椒磻?yīng)和蛋白質(zhì)印跡異常表達(dá)。此外,觀察到APRIL、BCMA和TACI的表達(dá)參與了A549細(xì)胞中細(xì)胞外信號(hào)調(diào)節(jié)激酶(ERK)1/2的激活。
關(guān)鍵字: TACI;TACI蛋白;TACI重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。